IMNN READ THE FULL IMNN RESEARCH REPORT Business Update First Patient Dosed in Phase 3 OVATION 3 Trial On July 30, 2025, Imunon, Inc. (NASDAQ:IMNN) announced that the first patient has been dosed in ...

The records from former Grand Rapids Police officer Christopher Schurr's murder trial are set to be destroyed, pending a final hearing later this month.

In attorney Marc Agnifilo's first network TV interview since Sean "Diddy" Combs' verdict, he recounted the most publicized ...

The new pill is a GLP-1 agonist, a type of medication which helps lower blood sugar levels, slows the digestion of food and ...

Metro's hometown-centric mixtape is the latest in a growing movement of Atlanta artists revisiting the city's early 2010s ...

The Jharkhand High Court has recently dismissed a petition filed under Article 227 of the Constitution, holding that a ...

Thomas Taylor, 17, was attacked by a group of teenagers and fatally stabbed near Bedford bus station on January 8, police ...

"He was gaining almost a pound a week," recalls his mother, Karen Freitag, who is grateful that a new medication helps her ...

Novo Nordisk has been losing big in the past year and is down over 66% from its peak in 2024. On the other hand, Eli Lilly ...

The driver, who is set to go on trial next month, had asked for the application to be continued, but Glasgow's licensing ...

Vance Boelter pleaded "not guilty" in federal court Thursday morning, August 7, to charges he killed former House Speaker Melissa Hortman and her husband after wounding Rep. John Hoffman and his wife.

Trials of a daily obesity pill have shown it can help patients lose around 12% of their body weight over 72 weeks. The ...